Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Reuters continues to rate PTSC "Outperform"; comparisons interesting
Reply New Message
Prev Message Back To Forum Threaded View Next Message

It would not be 39 x .45 (current share price) to figure PTSC's P/E (earnings), but rather the .05 we reported as earnings per share. Thus 39 x .05 = $1.95...which is where a lot of us have said we deserve to be. Alas, the market (read: MMs) say differently.

GLTA

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply